Slovakian CDMO Saneca ups capabilities after controlled release contract win

By Staff Reporter

- Last updated on GMT

Image: iStock/Fredex8
Image: iStock/Fredex8
Saneca Pharma will invest in its manufacturing site in Slovakia to service a five-year agreement supplying the Menarini Group with controlled release pellets.

The deal announced yesterday will see the Slovakian contract development and manufacturing organisation (CDMO) produce the controlled release pellets for one of the Menarini Group’s products from its facility in Hlohovec, about 50km northeast of Bratislava.

As part of the deal, Saneca is increasing the scale at which it can perform wurster coating – a technology for precision application of a film coating onto particulate materials such as powders, crystals, or granules - of the pellets.

The pellets themselves are made by extrusion spheronisation, “a method of wet granulation which makes strong dense pellets ideal for control release coating,”​ sales and marketing director Jeremy Drummond told

“The wet mass is extruded like spaghetti which falls on a rotating disc that rolls the broken ‘spaghetti’ into individual spheres.”

The firm’s technology will be used to produce enteric coated pellets aimed at preventing dissolution in the stomach, while allowing dissolution in the small intestine.

Drummond did not, however, disclose how much the firm would be investing to scale up coating.

He did say “Saneca has many years’ experience using the technology,”​ and “this is [just] one specialised technology ideal for controlled release products” which the firm offers for manufacturing solid dosage forms.

The deal is the latest form the CDMO which inked a 20 generic product production deal with Xantis Pharma in July​, and agreed to supply AMRI with opiate-intermediates in September last year​.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 04-May-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Access GMP process liquids

Access GMP process liquids

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Apr-2023 | Product Brochure

Accelerate your development and manufacturing of life-changing medicines with a reliable supply of your critical GMP-manufactured process liquids. Gibco...

Related suppliers

Follow us


View more